|1.||Guo, Fei: 3 articles (10/2015 - 02/2004)|
|2.||Li, Jie: 3 articles (11/2006 - 10/2003)|
|3.||Cao, Yong: 3 articles (11/2006 - 10/2003)|
|4.||Liu, Hongmei: 2 articles (06/2011 - 07/2006)|
|5.||Wang, Yang: 2 articles (08/2010 - 02/2004)|
|6.||Liu, Qiang: 2 articles (01/2004 - 10/2003)|
|7.||Yu, Lingfang: 1 article (10/2015)|
|8.||Guo, Ling: 1 article (10/2015)|
|9.||Liu, Sisun: 1 article (10/2015)|
|10.||Miao, Lifang: 1 article (10/2015)|
10/01/2003 - "It is indicated that lanthanum chloride might be effective in preventing scar development."
01/01/2004 - "Lanthanum chloride could inhibit the expressions of collagen protein, and it may be used to prevent and treat scars."
01/01/2004 - "To evaluate the effect of lanthanum chloride on expressions of collagen protein and find a way to prevent and treat scar. "
08/01/2010 - "Lanthanum chloride can inhibit the proliferation and migration of cervical cancer cells, and induce apoptosis by down-regulating cyclinD1, A20, and MMP-9 expressions in vitro."
08/01/2010 - "To investigate the effects of lanthanum chloride on proliferation and migration activity of human cervical cancer cells in vitro which may be a new anti-cervical cancer drug and provide experimental data for cervical cancer treatment. "
08/01/2010 - "[Effects of lanthanum chloride on proliferation and migration of human cervical cancer cell line HeLa cells]."
10/01/2015 - "This study provides novel evidence demonstrating that the anticancer mechanism of lanthanum chloride is partially attributed to miRNAs regulation and establishes an experimental basis for the clinical application of lanthanum chloride as an anti-cancer drug. "
10/01/2015 - "The effects of lanthanum chloride on proliferation and apoptosis of cervical cancer cells: involvement of let-7a and miR-34a microRNAs."
06/01/2011 - "Experimental studies have demonstrated that oral administration of lanthanum chloride (LaCl(3)) inhibits the development of atherosclerosis, but the related mechanism has not been fully elucidated. "
07/01/2006 - "Oral administration of lanthanum chloride (LaCl(3)) was reported to inhibit atherosclerosis in experimental animals, but the mechanism was not clear. "
03/01/1989 - "The ability of lanthanum chloride (LaCl3) to retard the progression of established atherosclerosis was investigated in cholesterol-fed rabbits. "
03/01/1989 - "Effect of lanthanum chloride on established atherosclerosis in the cholesterol-fed rabbit. "
|4.||Wounds and Injuries (Trauma)
10/01/2003 - "To investigate the effects of lanthanum chloride on the apoptosis of fibroblasts in trauma tissue. "
10/01/2003 - "[Effects of lanthanum chloride on the apoptosis of fibroblasts in trauma tissue]."
11/01/2006 - "The propose of the present study is to investigate the effects of lanthanum chloride (LaCl(3)), a rare earth compound, on extracellular matrix molecules in rat wound tissues, hoping to provide a clue for further study in reducing excessive extracellular matrix formation in trauma and burn, as well as in fibrous disorders. "
01/01/2004 - "[Effect of lanthanum chloride on expressions of collagen protein in a wound tissue]."
10/01/2003 - "0.25 ml of distilled water, lanthanum chloride (50 mmol/L) and the antibody of (TGFbeta(1)) transforming growth factor beta(1) (0.2 mg/ml) were respectively injected into the both sides of the other three wounds subcutaneously and the wounds were divided into simulating control (SC), lanthanum chloride (LC) and antibody (A) groups. "
02/02/2004 - "In this study, we explored the anti-LPS effects of lanthanum chloride in vivo so as to provide evidence in searching for new anti-endotoxic agents for the prevention and treatment of endotoxemia. "
02/02/2004 - "(2) In the mice with endotoxemia that were pretreated with lanthanum chloride the plasma TNFalpha level was 0.44 +/- 0.22 ng/ml and the TNFalpha mRNA expression in liver was (3.93 +/- 0.62) x 10(5) copies/ micro g RNA, both significantly lower than those of the mice with endotoxemia without pretreatment of lanthanum chloride, 0.99 +/- 0.24 ng/ml and (1.9 +/- 0.33) x 10(7) copies/ micro g RNA (both P < 0.001). "
|4.||Transforming Growth Factor beta (TGF-beta)
|5.||Calcium Channels (Calcium Channel)
|7.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|10.||Messenger RNA (mRNA)